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RESEARCH ARTICLE
Retrospective analysis of 286 Brucellosis cases in the southeast of Turkey
Türkiye’nin Güneydoğusunda 286 Brusellozis vakasının geriye dönük analizi
Recep Tekin1, Zehra Çağla Karakoç2, Özlem Demirpençe3, Fatma Bozkurt1, Özcan Deveci1, Duygu Mert4
ÖZET
Amaç: Çalışmamızda; Türkiye’nin Güneydoğu Anadolu 
bölgesinde yer alan Diyarbakır, Mardin ve Batman ille-
rindeki brusellozlu hastaların klinik, laboratuvar ve tedavi 
özellikleri yönünden değerlendirilmesi amaçlanmıştır.
Gereç ve yöntem: Haziran 2007- Temmuz 2009 tarihleri 
arasında  Enfeksiyon  Hastalıkları  ve  Klinik  Mikrobiyoloji 
Kliniğinde bruselloz tanısı ile izlenen 286 hasta geriye dö-
nük olarak değerlendirilmiştir.
Bulgular: Hastaların 156 (%55)’i kadın, 130 (%45)’i er-
kek ve yaş ortalamaları 32,8 + 15,3 (15-78) idi. Vakaların 
%75 akut, %23 subakut ve %2’sini kronik olarak grup-
landırıldı. Hastalığın bulaşmasındaki en önemli faktörün 
taze peynir yeme olduğu ve bölgede hayvan hareketle-
rinin kontrolünün olmadığı belirlendi. Hastalarda en sık 
rastlanan şikayetler yorgunluk, ateş, kas ve eklem ağrıları 
ve gece terlemesi idi. Ateş (%90,8), artrit (%54,1), spleno-
megali (%18,3) ve hepatomegali (%11) en sık rastlanan 
muayene bulgularıydı. Laboratuvarda ise C- Reaktif Pro-
tein (CRP) değerinin %60 yüksek olarak saptanması en 
sık rastlanan bulguydu. Tanı klinik belirtilerle birlikte pozitif 
Rose-Bengal ve Brusella tüp aglütinasyon testinin 1/160 
ve üzeri olması ile konuldu. Tedavide ise çoğunlukla ri-
fampisin ve doksisiklin kombinasyonu tercih edildi.
Sonuç:  Bruselloz  hala  ülkemizde  önemli  mortalite  ve 
morbiditeye neden olan bir halk sağlığı sorunudur. Bru-
cella, özellikle endemik bölgelerde, ateş, lökopeni ve os-
teoartiküler  bulguların  varlığında  ayırıcı  tanıda  mutlaka 
akılda bulundurulmalıdır.
Anahtar kelimeler:  Brucellosis,  Güneydoğu  Anadolu, 
Türkiye.
ABSTRACT
Objectives: The aim of this study was to evaluate the 
clinical,  laboratory  findings  and  therapeutic  features  of 
the patients inhabiting in Diyarbakır, Mardin and Batman 
province, in Southeastern Anatolia of Turkey.
Materials and methods: In this study, 286 patients with 
brucellosis, followed in departments of infectious diseas-
es and clinical microbiology between June 2007 and July 
2009, were evaluated retrospectively.
Results: One hundred fifty six (55%) of the patients were 
female and 130 (45%) were male. Mean age was 32.8 + 
15.3 (range15-78) years. The patients were categorized 
as acute (75%), subacute (23%) and chronic (2%) brucel-
losis. Major transmission route was the consumption of 
unpasteurized fresh cheese. The transport of animals in 
the region is not controlled. Malaise, fever, myalgia ar-
thralgia and sweating were the most frequently observed 
symptoms. The most common signs were fever 90.8%, 
arthritis 54.1%, splenomegaly 18.3% and hepatomegaly 
11%. The most frequent laboratory finding was a high C-
reactive protein level (60%). Diagnosis was made based 
on  the  clinical  features  and  positive  Rose-Bengal  test 
combination with an initial Brucella antibody titer greater 
than or equal to 1/160. The most frequently preferred an-
timicrobial regimen was rifampin and doxycycline combi-
nation.
Conclusions:  Brucellosis  is  still  an  important  public 
health problem in Turkey. The disease has an important 
morbidity  and  mortality.  Brucellosis  should  be  kept  in 
mind in endemic regions of our country with the symp-
toms of fever, leukopenia and osteoarticular symptoms. J 
Clin Exp Invest 2012; 3 (3): 335-339
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INTRODUCTION
Brucellosis is a zoonosis, which exists worldwide, 
but it is especially prevalent in the Mediterranean 
basin including Turkey. Major route of transmission 
to  humans  include  by  ingestion  of  unpasteurized 
dairy products of an infected animal.1 Disease can 
be categorized as acute (<8 weeks), subacute (8-52 
weeks) and chronic (>52 weeks) brucellosis accord-
ing to the onset of symptoms. Symptoms of acute 
brucellosis  are  fever,  sweats,  malaise,  anorexia, 
headache and back pain, which are nonspecific. In 
subacute cases undulant fever and muscle-skeletal 
system symptoms are predominant. In cases with 
chronic  brucellosis,  symptoms  can  recur  for  long 
period of time and low-grade fever, neuropsychiat-
ric complaints can be seen.2 The diagnosis is made 
with certainty when Brucella recovered from blood, 
bone marrow or other tissues.1 The rate of isolation 
ranges from 15% to more than 90% depending on 
the methods used.3,4 A variety of tests have been 
applied  to  the  serologic  diagnosis  of  brucellosis, 
of which are Serum Agglutination test (SAT), Rose 
Bengal test or ELISA.5,6
The aim of this study was to evaluate the de-
mographic, clinical, laboratory findings and thera-
peutic features of the 286 brucellosis cases.
MATERIALS AND METHODS
This retrospective study included 286 patients who 
were diagnosed with brucellosis and treated at the 
Mardin State Hospital, Nusaybin State Hospital and 
Batman  State  Hospital  Infectious  Diseases  and 
Clinical  Microbiology  clinics  between  September 
2007 and October 2009. Demographic data, clinical 
symptoms and signs, laboratory findings and thera-
peutic features of the patients were analyzed from 
the outpatient unit cards. Patients were categorized 
as acute (<8 weeks), subacute (8-52 weeks) and 
chronic  (>52  weeks)  brucellosis  according  to  the 
onset of symptoms. The diagnosis based on clini-
cal findings compatible with brucellosis (fever, ar-
thralgia, sweating, malaise, hepatomegaly, spleno-
megaly, lymphadenopathy, signs of focal disease), 
supported by detection of positive Rose-Bengal test 
combination with specific antibodies at significant 
titers and/or demonstration of at least 4-fold rise in 
antibody titer in serum samples obtained 3-4 weeks 
apart. Antibody titers were determined by standard 
tube agglutination (STA), Brucella coombs test or 
Brucellacapt assay (5,6). The titers were equal or 
greater  than  1/160  are  considered  diagnostic  in 
conjunction with a compatible clinical presentation. 
During the study period, bacterial isolation was 
not a routine practice because of the lack of condi-
tions in Mardin, Nusaybin and Batman State Hospi-
tals. X-rays, ultrasonography (USG), computerized 
tomography (CT), magnetic resonance (MR) imag-
ing, echocardiography, and lumbar puncture were 
performed in order to examine complications. Re-
lapse was defined as reappearance of symptoms 
and signs after the completion of treatment in one-
year duration of time. Therapeutic failure was de-
fined as persistence of symptoms and signs attrib-
utable to disease after completion of therapy.
Statistical analysis was performed using SPSS. 
Chi- square test or Fisher exact test were used for 
categorical variables. The probability value for sta-
tistical significance was set as <0.05.
RESULTS
Two hundred eighty six patients were included in 
the study. One hundred fifty six (55%) of the pa-
tients were female and 130 (45%) were male. Mean 
age was 32.8 +-15.3 (range 15-78) years. Most pa-
tients are in the 15-20 years and 21-30 years age 
groups (Figure 1).
Figure 1. The patients’ dis-
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The time between the onset of symptoms and 
clinical  presentation  ranged  from  1  week  to  11 
months in patients. In terms of clinical forms; 75% 
(n: 215) of the patients were acute, 23% (n: 66) were 
subacute, 2% (n: 5) were chronic. In patients most 
clinical symptom was fever, which is presented in 
acute form 95 % (n: 204), 41% (n: 27) in subacute 
form,  40%  (n:  2)  in  chronic  form.  Other  frequent 
symptoms are night sweating 69% (n: 198), muscle 
pain 64% (n: 183), malaise 63% (n: 179), and joint 
pain %62 (n: 177). Major clinical findings in patients 
were fever (79%) (Table 1). 
Table 1. Clinical characteristics and outcomes of the 286 
patients with Brucellosis
n %
Symptoms and signs of patients
Fever 233 81
Night sweating 198 69
Myalgia  183 64
Malaise  179 63
Joint pain 177 62
Lumbar pain  165 58
Sacral pain 162 57
Limitation of movement 102 36
Headache 96 34
Anorexia 39 14
Vomiting 14 5
Abdominal pain 12 4
Icterus  3 1
Scrotal pain 3 1
Unconsciousness 1 0,3
Physical and clinical findings of the patients
Fever 227 79
Arthralgia 156 55
Hepatomegaly 92 32
Splenomegaly 69 24
Sacroiliitis 124 43
Lymphadenopathy 12 4
Icterus 3 1
Neck stiffness 1 0,3
Laboratory findings of the patients
Leukocyte/μl
<4600 59 21
4600-10 200 217 76
>10 200  10 3
Lymphocytes ≥ %40  115 40
Platelet <142 000/μl  83 29
Alanine transaminase >35 IU/L  151 52
Aspartate transaminase >40 IU/L  139 49
Total bilirubin >1.2 mg/dl  74 26
Erythrocyte sedimentation rate >20 mm/h 162 57
C- Reactive protein >5 mg/dl  247 86
The others are sacroiliitis (43%), hepatomegaly 
(32%),  and  splenomegaly  (24%).  Clinical,  demo-
graphic, laboratory features and outcomes of the 
286 cases with brucellosis were summarized in de-
tail in Table 2. Antibiotic combinations used were; 
rifampin+doxycycline  76%  (n:  217),  streptomycin 
+ doxycycline 13% (n: 38), streptomycin+doxycyc
line+rifampin 8% (n: 24), ceftriaxone+rifampin 1% 
(n:  3),  doxycycline+trimetoprim-sulfamethoxazole 
(TMP-SMZ) (n: 2), TMP-SMZ+ rifampin + ceftriax-
one (n: 1). Major consumption of route was unpas-
teurized fresh cheese and milk 79% (n: 225) of pa-
tients. Thirty five percent (n: 105) of patients were 
farmers  and  16%  (n:  46)  had  brucellosis  in  their 
family members.
DISCUSSION
Brucellosis is an endemic zoonosis and a serious 
public health problem in Turkey. Among high-risk 
patients in the eastern part of Turkey, seropositivity 
has been reported to be as high as 27.2%.7 How-
ever, the true rates of brucellosis in endemic coun-
tries are most probably higher than reported due to 
deficiencies in its diagnosis or recording.8
Brucellosis can occur at any age but it is most 
common in adolescents and young adults and both 
sexes are affected equally.9 In our study most af-
fected age groups are the 15-20 years, 21-30 years 
groups  but  females  (55%)  were  slightly  more  af-
fected than males (45%). This may be attributed to 
involvement in the raising of livestock at a younger 
age and in most of the families particularly house-
wives take active duty in the raising of livestock in 
our region.10,11
It  was  detected  that  at  least  one  epidemio-
logical  resource  particularly  including  raising  the 
livestock and consumption the raw milk and milk 
of  products  accounts  for  76.7-  87%  of  cases  in 
Southeast and Central Anatolia Regions, where the 
incidence of the disease is high.12 There was a his-
tory of consuming unpasteurized fresh cheese and 
milk in 79% (n=225) of our patients, farming in 35% 
(n=105)  and  16%  (n=46)  had  brucellosis  in  their 
family members. Primary transmission route of the 
disease is consumption of unpasteurized dairy prod-
ucts in endemic countries, whereas in developed 
countries is frequent more transmission is through 
the direct contact and the inhalation.13 A history of 
raw dairy product consumption was present in 79% 
of the cases in our study, which was consistent with 
epidemiologic studies from Turkey.10,11,14-17 A history 
of  livestock  raising  has  been  shown  for  between 
14.6% and 70.3% of cases in studies carried out in Tekin et al. Brucellosis in southeast of Turkey 338
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Turkey.11,12,14,15,18-21 In our study, there was a history 
of livestock raising in 35% as accordance with the 
previous studies from Turkey. In previous reports, a 
family history of brucellosis has been reported for 
between 12.6% and 43% of cases in Turkey,10,14,15,21 
and also in 9.6% in the study by Roushan et al.16 
from Iran. In our study, a family history was present 
in 17.8% of patients. This may be attributed to the 
presence of larger families in our region.
Brucellosis may appear in four different forms, 
namely acute, subacute, chronic, and relapse.1,23,24 
In  this  study,  the  acute  presentation  constituted 
most of the cases (75%), whereas subacute and 
chronic cases constituted 23% and 2% of the cas-
es, respectively; this is in accordance with previ-
ous  reports.14,25  Typically  acute  brucellosis  cases 
present with chills, fever, fatigue, sweating, weight 
loss, and back pain.1,23 Subacute cases show a pro-
tean clinical presentation, although with less severe 
symptoms  compared  to  the  acute  form.  Patients 
with the chronic form of the disease usually present 
with complaints of malaise, nervousness, emotional 
lability, depression, or generalized musculoskeletal 
pain.23-28 In our study population, fever was most 
clinical  symptom.  Other  frequent  symptoms  were 
sweating, myalgia, malaise and arthralgia. As are 
available in the literature in our cases, fever was 
seen  as  the  most  clinical  finding.  That  followed 
arthralgia,  sacroiliitis  and  hepatomegaly  respec-
tively.  Leukopenia,  thrombocytopenia,  elevated 
liver enzymes, and increased CRP were the most 
prominent  laboratory  abnormalities  seen  in  acute 
and subacute cases. Increased ESR and lympho-
monocytosis were observed to the same extent in 
all forms.1,23,24
Brucella infection may involve any organ or tis-
sue in the body. Organ involvement can be assigned 
as focal involvement or as a complication. The most 
common systems affected are the locomotor, gas-
trointestinal, genitourinary, hematologic, cardiovas-
cular, respiratory, and central nervous systems. As 
the largest organ of the reticuloendothelial system, 
the liver is affected in almost all patients with bru-
cellosis. Liver involvement results in mild to mod-
erate elevation in liver enzymes.1,7,27 In laboratory 
findings of our patients, liver enzyme elevation was 
observed in 52% of the cases.
 In conclusion, brucellosis is hyperendemic in 
Turkey, where the disease is transmitted mainly by 
unpasteurized milk and milk products. Thus, pre-
vention  depends  on  eliminating  the  disease  from 
domestic animals and educating people to use pas-
teurized products.
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